FDA Warns on Using Surgical Device for Aesthetic Skin Procedures

Posted By American Med Spa Association, Wednesday, March 16, 2022

The FDA on Monday warned against using the Renuvion/J-Plasma device for dermal resurfacing or skin contraction procedures, describing serious and potentially life-threatening adverse events (AEs) following its use for such purposes.

Renuvion/J-Plasma -- which uses radiofrequency energy and helium to generate a hot gas-like substance (plasma) that can cut through tissue -- is cleared for cutting, coagulation, and ablation of soft tissue during general surgery. But "the use of this device has not been determined to be safe or effective for any specific procedure intended to improve the appearance of the skin," the agency explained in a statement.

The FDA detailed a host of serious AEs after use of Apyx Medical's device for aesthetic skin procedures (with or without liposuction), including "second- and third- degree burns, infection, change in skin color, scars, nerve damage, significant bleeding, and air or gas accumulation under the skin, in body cavities, and in blood vessels."

In some cases, the AEs were serious enough to land patients in intensive care.
"Do not use the Renuvion/J-Plasma device for dermal resurfacing or skin contraction, alone or in combination with liposuction," FDA warned healthcare providers. "If you are performing an aesthetic procedure, inform your patient which devices you plan to use."
Read more at MedPage Today >>